Headline News about Merck & Co
(MRK) - Analyzing Merck & Co's Short Interest
December 04, 2023
Via Benzinga
Price Over Earnings Overview: Merck & Co
November 30, 2023
Via Benzinga
Analyst Ratings for Merck & Co
November 29, 2023
Via Benzinga
FDA Approves Merck's Blockbuster Cancer Drug For Type Of Gastric Cancer
November 17, 2023
Via Benzinga
Exposures
Product Safety
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
Via Benzinga
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|